US FDA Testing Finds Consumer Health Market Problems, But It Can’t Test Entire Marketplace
Executive Summary
CDER compliance office director Donald Ashley offers a cautionary note to temper expectations for the FDA’s enforcement in the supplement sector. “We continue to warn the public about products very often sold as dietary supplements that contain hidden drugs,” he says.
You may also be interested in...
‘Go Try To Find Some Zinc Gluconate’: The Dietary Supplement Supply Chain Entering 2022
Ingredients for immune health supplements are in short supply as high demand persists in the US. CEOs Mark LeDoux of Natural Alternatives International and Jim Emme of NOW Health Group, both on the Natural Products Association’s board of directors, discuss ongoing supply issues and best practices to avoid problems.
OTC Sanitizer Contaminations Drop In US As Auxiliary Manufacturers Stop Production
"Fewer people are manufacturing the products ... That seems to be a sort of a natural reaction to I think the decreased consumer demand," says Donald Ashley, compliance chief in FDA’s drug center.
Amazon Response About Drug-Spiked Supplements ‘Not Sufficient To Protect Public’ – FDA
“Amazon has taken some action when alerted by the FDA about sales” of violative supplements, but FDA "found that other such products continue to be offered for sale” by the firm through its Fulfillment by Amazon service, according to untitled letter.